» Articles » PMID: 29855666

An Adult-based Insulin Resistance Genetic Risk Score Associates with Insulin Resistance, Metabolic Traits and Altered Fat Distribution in Danish Children and Adolescents Who Are Overweight or Obese

Abstract

Aims/hypothesis: A genetic risk score (GRS) consisting of 53 insulin resistance variants (GRS) was recently demonstrated to associate with insulin resistance in adults. We speculated that the GRS might already associate with insulin resistance during childhood, and we therefore aimed to investigate this in populations of Danish children and adolescents. Furthermore, we aimed to address whether the GRS associates with components of the metabolic syndrome and altered body composition in children and adolescents.

Methods: We examined a total of 689 children and adolescents who were overweight or obese and 675 children and adolescents from a population-based study. Anthropometric data, dual-energy x-ray absorptiometry scans, BP, fasting plasma glucose, fasting serum insulin and fasting plasma lipid measurements were obtained, and HOMA-IR was calculated. The GRS was examined for association with metabolic traits in children by linear regressions using an additive genetic model.

Results: In overweight/obese children and adolescents, the GRS associated with higher HOMA-IR (β = 0.109 ± 0.050 (SE); p = 2.73 × 10), fasting plasma glucose (β = 0.010 ± 0.005 mmol/l; p = 2.51 × 10) and systolic BP SD score (β = 0.026 ± 0.012; p = 3.32 × 10) as well as lower HDL-cholesterol (β = -0.008 ± 0.003 mmol/l; p = 1.23 × 10), total fat-mass percentage (β = -0.143 ± 0.054%; p = 9.15 × 10) and fat-mass percentage in the legs (β = -0.197 ± 0.055%; p = 4.09 × 10). In the population-based sample of children, the GRS only associated with lower HDL-cholesterol concentrations (β = -0.007 ± 0.003 mmol/l; p = 1.79 × 10).

Conclusions/interpretation: An adult-based GRS comprising 53 insulin resistance susceptibility SNPs associates with insulin resistance, markers of the metabolic syndrome and altered fat distribution in a sample of Danish children and adolescents who were overweight or obese.

Citing Articles

Polygenic Score Approach to Predicting Risk of Metabolic Syndrome.

Timasheva Y, Kochetova O, Balkhiyarova Z, Korytina G, Prokopenko I, Nouwen A Genes (Basel). 2025; 16(1).

PMID: 39858569 PMC: 11764775. DOI: 10.3390/genes16010022.


Genetic Susceptibility to Insulin Resistance and Its Association with Estimated Longevity in the Hungarian General and Roma Populations.

Piko P, Werissa N, Adany R Biomedicines. 2022; 10(7).

PMID: 35885008 PMC: 9313401. DOI: 10.3390/biomedicines10071703.


The Genetics of Type 2 Diabetes in Youth: Where We Are and the Road Ahead.

Srinivasan S, Todd J J Pediatr. 2022; 247:17-21.

PMID: 35660490 PMC: 9833991. DOI: 10.1016/j.jpeds.2022.05.044.


Relationship between glucose homeostasis and obesity in early life-a study of Italian children and adolescents.

Balkhiyarova Z, Luciano R, Kaakinen M, Ulrich A, Shmeliov A, Bianchi M Hum Mol Genet. 2021; 31(5):816-826.

PMID: 34590674 PMC: 8895752. DOI: 10.1093/hmg/ddab287.


Genetic Risk Score for Type 2 Diabetes and Traits Related to Glucose-Insulin Homeostasis in Youth: The Exploring Perinatal Outcomes Among Children (EPOCH) Study.

Stanislawski M, Litkowski E, Raghavan S, Harrall K, Shaw J, Glueck D Diabetes Care. 2021; 44(9):2018-2024.

PMID: 34257098 PMC: 8740919. DOI: 10.2337/dc21-0464.


References
1.
FRIEDEWALD W, Levy R, Fredrickson D . Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18(6):499-502. View

2.
Zoungas S, Woodward M, Li Q, Cooper M, Hamet P, Harrap S . Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes. Diabetologia. 2014; 57(12):2465-74. DOI: 10.1007/s00125-014-3369-7. View

3.
Vassy J, Hivert M, Porneala B, Dauriz M, Florez J, Dupuis J . Polygenic type 2 diabetes prediction at the limit of common variant detection. Diabetes. 2014; 63(6):2172-82. PMC: 4030114. DOI: 10.2337/db13-1663. View

4.
. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004; 114(2 Suppl 4th Report):555-76. View

5.
Jorgensen T, Borch-Johnsen K, Thomsen T, Ibsen H, Glumer C, Pisinger C . A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. Eur J Cardiovasc Prev Rehabil. 2003; 10(5):377-86. DOI: 10.1097/01.hjr.0000096541.30533.82. View